ArticleArthroplasty (London, England)2025
Complications of total hip and knee arthroplasty in solid organ transplant patients: a systematic review and meta-analysis.
Article in Arthroplasty (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of solid organ transplant on postoperative outcomes following lumbar spine fusion surgery: A propensity-matched retrospective cohort analysis.North American Spine Society journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis systematic review and meta-analysis aimed to quantify risks of complications associated with total hip and knee arthroplasty (THA, TKA) in patients with solid organ transplants (SOT) compared to the general population.
methodsThe study was pre-registered on PROSPERO (CRD42023399043). Literature searches were performed looking for comparative studies reporting postoperative complication data of THA or TKA in patients with kidney, liver, pancreas, heart, or lung transplants versus controls. Outcomes of interest included incidence of blood transfusion, periprosthetic joint infection (PJI), periprosthetic fracture, deep venous thrombosis (DVT), pulmonary embolism (PE), mortality, hospital re-admission, and all-cause revision. The Newcastle Ottawa scale was used to assess study quality, and the GRADE for certainty of evidence.
resultsA total of 13 studies participated in meta-analyses (10 in THA, 3 in TKA). Compared to controls, SOT patients (mixed data from all transplant types) had a significantly higher incidence of blood transfusion [THA OR 1.57 (1.36-1.80), TKA OR 1.37 (1.15-1.63)], PJI [THA OR 1.78 (1.01-3.12), TKA 3.11 (1.16-8.35)], DVT [THA OR 1.32 (1.04-1.66), TKA OR 1.56 (1.36-1.78)], and all-cause revision [only TKA OR 1.37 (1.15-1.63)]. THA in kidney transplant patients was associated with higher early mortality [OR 2.12 (1.38-3.25)] and 30-day re-admission [OR 1.62 (1.31-2.00)] compared to the general population. SOT was not associated with a higher incidence of post-operative PE after either THA or TKA [OR 0.94 (0.66-1.34), OR 0.89 (0.55-1.43), respectively]. The incidence of THA dislocation in mixed analyses with all SOT types was not statistically significant despite the unfavourable OR [1.62 (0.94-2.78)], but it was in the kidney and heart transplant subgroup analyses (OR 1.41 (1.16-1.73), OR 2.17 (1.47-3.20), respectively). The incidence of periprosthetic fracture was not higher in SOT patients compared to controls in those undergoing a THA [OR 1.07 (0.84-1.36)], but it was after a TKA [OR 1.79 (1.36-2.36)].
conclusionTHA and TKA are associated with an unfavourable complication profile in SOT patients compared to the general population. Decisions for or against arthroplasty surgery should be made on an individual basis with a multidisciplinary approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.